"We've been fighting cancer for more than nine years now and we can't do any of the things we wanted to do. We really resent Monsanto for that," Pilliod said.The prior two jury verdicts against Bayer in U.S. Roundup trials triggered steep declines in Bayer shares.A San Francisco state court jury in August 2018 awarded $289 million to a California groundskeeper, finding Monsanto's glyphosate-based weed killers caused his cancer. That award was later reduced to $78 million and is on appeal.In March, a federal jury in San Francisco awarded $80 million to another California man after finding Roundup caused his cancer. "The legal questions on appeal in the previous two cases will ultimately inform how this litigation proceeds," Zimmerman said. Bayer denies those allegations.Lawsuits are largely based on a 2015 conclusion by the World Health Organization's cancer arm, which classified glyphosate as "probably carcinogenic to humans.

Source: Economic Times May 14, 2019 03:45 UTC